Skip to main content
Top
Published in:

28-09-2024 | Bariatric Surgery

Association between bariatric surgery preoperative chemoprophylaxis and postoperative bleeding

Authors: Joseph E. Sanchez, Audra Reiter, Catherine S. Valukas, Whitney N. Jones, Dominic J. Vitello, Joanne Prinz, Yan Li, Eric S. Hungness, Ezra N. Teitelbaum

Published in: Surgical Endoscopy | Issue 12/2024

Login to get access

Abstract

Background

Use of chemoprophylaxis for prevention of venous thromboembolism (VTE) after bariatric surgery is a generally accepted principle; however, the optimal strategy in terms of medication type and pre- and postoperative dosing is uncertain. In our healthcare system, four hospitals performed bariatric surgery and utilized differing protocols for VTE prophylaxis. The analysis sought to evaluate the association of differing prophylaxis strategies on bleeding and VTE occurrence.

Methods

Adult patients who underwent laparoscopic sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) from 2018 to 2021 at four hospitals were studied. Patients were grouped by whether or not they received preoperative chemoprophylaxis. The primary outcome was postoperative bleeding, defined as requiring a blood transfusion or reoperation for bleeding within 30 days. Bivariate analyses were performed with Chi-square and Wilcoxon Rank tests where applicable. Multivariate logistic regression was performed for the outcome of postoperative bleeding.

Results

A total of 2145 bariatric surgeries were evaluated (33.6% RYGB, 66.4% SG). Among 1712 patients who underwent surgery at Hospitals A, B, and C, 93.1% received preoperative VTE prophylaxis, compared with 1 patient (0.1%) among 433 patients operated on at Hospital D. Postoperative bleeding occurred more frequently in patients who received preoperative VTE prophylaxis versus those who did not (3.7% vs 1.1%; p < 0.01). After multivariable regression analysis, only RYGB (OR 3.59; p < 0.01) and preoperative VTE prophylaxis (OR 3.54; p = 0.02) were significantly associated with postoperative bleeding. Rates of VTE for patients receiving preoperative VTE prophylaxis or no prophylaxis were not significantly different (0.6% vs. 0.2%; p = 0.26).

Discussion

Preoperative VTE prophylaxis prior to bariatric surgery was associated with postoperative bleeding without differences in VTE occurrence. These results call into question the routine use of VTE chemoprophylaxis for all patients undergoing bariatric surgery and favor selective usage.
Literature
1.
go back to reference Aminian A, Vosburg RW, Altieri MS, Hinojosa MW, Khorgami Z (2022) The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery. Surg Obes Relat Dis 18(2):165–174CrossRefPubMed Aminian A, Vosburg RW, Altieri MS, Hinojosa MW, Khorgami Z (2022) The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery. Surg Obes Relat Dis 18(2):165–174CrossRefPubMed
2.
go back to reference Becattini C, Agnelli G, Manina G, Noya G, Rondelli F (2012) Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis 8(1):108–115CrossRefPubMed Becattini C, Agnelli G, Manina G, Noya G, Rondelli F (2012) Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis 8(1):108–115CrossRefPubMed
3.
go back to reference Imberti D, Baldini E, Pierfranceschi MG, Nicolini A, Cartelli C, De Paoli M et al (2014) Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospectivandomizedsed pilot study evaluating two doses of parnaparin (BAFLUX Study). Obes Surg 24:284–291CrossRefPubMed Imberti D, Baldini E, Pierfranceschi MG, Nicolini A, Cartelli C, De Paoli M et al (2014) Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospectivandomizedsed pilot study evaluating two doses of parnaparin (BAFLUX Study). Obes Surg 24:284–291CrossRefPubMed
4.
go back to reference Hamad GG, Bergqvist D (2007) Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surg Obes Relat Dis 3(1):97–102CrossRefPubMed Hamad GG, Bergqvist D (2007) Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surg Obes Relat Dis 3(1):97–102CrossRefPubMed
5.
go back to reference Finks JF, English WJ, Carlin AM, Krause KR, Share DA, Banerjee M et al (2012) Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg 255(6):1100–1104CrossRefPubMed Finks JF, English WJ, Carlin AM, Krause KR, Share DA, Banerjee M et al (2012) Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg 255(6):1100–1104CrossRefPubMed
6.
go back to reference Nimeri AA, Bautista J, Ibrahim M, Philip R, Al Shaban T, Maasher A, Altinoz A (2018) Mandatory risk assessment reduces venous thromboembolism in bariatric surgery patients. Obes Surg 28:541–547CrossRefPubMed Nimeri AA, Bautista J, Ibrahim M, Philip R, Al Shaban T, Maasher A, Altinoz A (2018) Mandatory risk assessment reduces venous thromboembolism in bariatric surgery patients. Obes Surg 28:541–547CrossRefPubMed
7.
go back to reference Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 13(6):819–825CrossRefPubMed Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 13(6):819–825CrossRefPubMed
8.
go back to reference Brotman DJ, Shihab HM, Prakasa KR, Kebede S, Haut ER, Sharma R et al (2013) Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis. JAMA Surg 148(7):675–686CrossRefPubMed Brotman DJ, Shihab HM, Prakasa KR, Kebede S, Haut ER, Sharma R et al (2013) Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis. JAMA Surg 148(7):675–686CrossRefPubMed
9.
go back to reference Abdelsalam AM, ElAnsary AMSE, Salman MA, Nassef SA, Elfergany HM, Aisha HAA (2021) Adding a preoperative dose of LMWH may decrease VTE following bariatric surgery. World J Surg 45:126–131CrossRefPubMed Abdelsalam AM, ElAnsary AMSE, Salman MA, Nassef SA, Elfergany HM, Aisha HAA (2021) Adding a preoperative dose of LMWH may decrease VTE following bariatric surgery. World J Surg 45:126–131CrossRefPubMed
10.
go back to reference Dick A, Byrne TK, Baker M, Budak A, Morgan K (2010) Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe? Surg Obes Relat Dis 6(6):643–647CrossRefPubMed Dick A, Byrne TK, Baker M, Budak A, Morgan K (2010) Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe? Surg Obes Relat Dis 6(6):643–647CrossRefPubMed
11.
go back to reference Nielsen AW, Helm MC, Kindel T, Higgins R, Lak K, Helmen ZM, Gould JC (2018) Perioperative bleeding and blood transfusion are major risk factors for venous thromboembolism following bariatric surgery. Surg Endosc 32:2488–2495CrossRefPubMed Nielsen AW, Helm MC, Kindel T, Higgins R, Lak K, Helmen ZM, Gould JC (2018) Perioperative bleeding and blood transfusion are major risk factors for venous thromboembolism following bariatric surgery. Surg Endosc 32:2488–2495CrossRefPubMed
12.
go back to reference Bakhos C, Alkhoury F, Kyriakides T, Reinhold R, Nadzam G (2009) Early postoperative hemorrhage after open and laparoscopic roux-en-y gastric bypass. Obes Surg 19:153–157CrossRefPubMed Bakhos C, Alkhoury F, Kyriakides T, Reinhold R, Nadzam G (2009) Early postoperative hemorrhage after open and laparoscopic roux-en-y gastric bypass. Obes Surg 19:153–157CrossRefPubMed
13.
go back to reference Aminian A, Andalib A, Khorgami Z, Cetin D, Burguera B, Bartholomew J et al (2017) Who should get extended thromboprophylaxis after bariatric surgery?: a risk assessment tool to guide indications for post-discharge pharmacoprophylaxis. Ann Surg 265(1):143–150CrossRefPubMed Aminian A, Andalib A, Khorgami Z, Cetin D, Burguera B, Bartholomew J et al (2017) Who should get extended thromboprophylaxis after bariatric surgery?: a risk assessment tool to guide indications for post-discharge pharmacoprophylaxis. Ann Surg 265(1):143–150CrossRefPubMed
14.
go back to reference Gagner M, Selzer F, Belle SH, Bessler M, Courcoulas AP, Dakin GF et al (2012) Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 8(6):663–670CrossRefPubMedPubMedCentral Gagner M, Selzer F, Belle SH, Bessler M, Courcoulas AP, Dakin GF et al (2012) Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 8(6):663–670CrossRefPubMedPubMedCentral
15.
go back to reference Bartlett MA, Mauck KF, Daniels PR (2015) Prevention of venous thromboembolism in patients undergoing bariatric surgery. In: Vascular health and risk management, pp 461–477 Bartlett MA, Mauck KF, Daniels PR (2015) Prevention of venous thromboembolism in patients undergoing bariatric surgery. In: Vascular health and risk management, pp 461–477
16.
go back to reference Reiter AJ, Prinz J, Li Y, Nagle AP, Hungness ES, Teitelbaum EN (2023) Increased bleeding risk with enoxaparin venothromboembolism prophylaxis compared with heparin in patients undergoing bariatric surgery. Surg Endosc 1–6 Reiter AJ, Prinz J, Li Y, Nagle AP, Hungness ES, Teitelbaum EN (2023) Increased bleeding risk with enoxaparin venothromboembolism prophylaxis compared with heparin in patients undergoing bariatric surgery. Surg Endosc 1–6
17.
go back to reference Bartlett MA, Mauck KF, Stephenson CR, Ganesh R, Daniels PR (2020). Perioperative venous thromboembolism prophylaxis. In: Mayo clinic proceedings, vol 95, no 12. Elsevier, pp 2775–2798 Bartlett MA, Mauck KF, Stephenson CR, Ganesh R, Daniels PR (2020). Perioperative venous thromboembolism prophylaxis. In: Mayo clinic proceedings, vol 95, no 12. Elsevier, pp 2775–2798
18.
go back to reference Wang Q, Ding J, Yang R (2021) The venous thromboembolism prophylaxis in patients receiving thoracic surgery: a systematic review. Asia Pac J Clin Oncol 17(5):e142–e152CrossRefPubMed Wang Q, Ding J, Yang R (2021) The venous thromboembolism prophylaxis in patients receiving thoracic surgery: a systematic review. Asia Pac J Clin Oncol 17(5):e142–e152CrossRefPubMed
19.
go back to reference Bellomy ML, Engoren MC, Martin BJ, Shi Y, Shotwell MS, Hughes CG, Freundlich RE (2021) The attributable mortality of postoperative bleeding exceeds the attributable mortality of postoperative venous thromboembolism. Anesth Analg 132(1):82–88CrossRefPubMedPubMedCentral Bellomy ML, Engoren MC, Martin BJ, Shi Y, Shotwell MS, Hughes CG, Freundlich RE (2021) The attributable mortality of postoperative bleeding exceeds the attributable mortality of postoperative venous thromboembolism. Anesth Analg 132(1):82–88CrossRefPubMedPubMedCentral
20.
go back to reference Helm JH, Helm MC, Kindel TL, Gould JC, Higgins RM (2019) Blood transfusions increase the risk of venous thromboembolism following ventral hernia repair. Hernia 23:1149–1154CrossRefPubMed Helm JH, Helm MC, Kindel TL, Gould JC, Higgins RM (2019) Blood transfusions increase the risk of venous thromboembolism following ventral hernia repair. Hernia 23:1149–1154CrossRefPubMed
Metadata
Title
Association between bariatric surgery preoperative chemoprophylaxis and postoperative bleeding
Authors
Joseph E. Sanchez
Audra Reiter
Catherine S. Valukas
Whitney N. Jones
Dominic J. Vitello
Joanne Prinz
Yan Li
Eric S. Hungness
Ezra N. Teitelbaum
Publication date
28-09-2024
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 12/2024
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-024-11288-7
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now